AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹8.12 Cr | ₹4.42 Cr | ₹4.03 Cr | ₹6.76 Cr | ₹82 Cr |
What is the latest Contingent Liabilities ratio of AJANTA PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹8.12 Cr |
| Mar2024 | ₹4.42 Cr |
| Mar2023 | ₹4.03 Cr |
| Mar2022 | ₹6.76 Cr |
| Mar2021 | ₹82 Cr |
How is Contingent Liabilities of AJANTA PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.12 Cr | 83.71 | |
| Mar2024 | ₹4.42 Cr | 9.68 | |
| Mar2023 | ₹4.03 Cr | -40.38 | |
| Mar2022 | ₹6.76 Cr | -91.74 | |
| Mar2021 | ₹82 Cr | - | |
Compare Contingent Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹32,616.4 Cr | 6.1% | 8.7% | -15.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 6.1% |
8.7% |
-15.2% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses